PRGO
Perrigo Company plc
PRGO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
PRGO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Weak |
PRGO's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
PRGO PE Valuation
PRGO has no meaningful PE right now: it lost money over the past year.
PRGO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect PRGO's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
PRGO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.53 | — |
| Q3 2026 | -$12.77 | -$12.39 |
| Q2 2026 | -$12.52 | -$11.94 |
| Q1 2026 | -$13.11 | -$11.80 |
| Q4 2025 | -$10.29 | -$9.04 |
| Q3 2025 | -$0.38 | +$0.78 |
| Q2 2025 | -$0.58 | +$0.33 |
| Q1 2025 | -$1.31 | -$1.25 |
| Q4 2024 | -$1.25 | -$1.16 |
PRGO lost $12.77 per share over the past year, a bigger loss than the year before.
PRGO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $988.6M | -5.2% |
| Q2 2026 | $1B | -3.2% |
| Q1 2026 | $969.2M | -7.2% |
| Q4 2025 | $1.1B | -2.5% |
| Q3 2025 | $1B | -4.1% |
| Q2 2025 | $1.1B | -0.9% |
| Q1 2025 | $1B | -3.5% |
| Q4 2024 | $1.1B | -1.6% |
PRGO's revenue has slid since its 2020 peak: $989M last quarter, down 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.3% | -4.6 points |
| Q2 2026 | 2.3% | -2 points |
| Q1 2026 | -38% | -43 points |
| Q4 2025 | -116% | -126 points |
| Q3 2025 | 7% | -0.4 points |
| Q2 2025 | 4.3% | +6.8 points |
| Q1 2025 | 4.5% | +9.6 points |
| Q4 2024 | 10% | +11 points |
PRGO's operating margin was 2.3% last quarter, down 4.6 points from the same quarter a year ago.
PRGO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.7M | +164% |
| Q2 2026 | $68.3M | +20% |
| Q1 2026 | -$127.4M | -$37.4M |
| Q4 2025 | $148.6M | -46% |
| Q3 2025 | $29.8M | +97% |
| Q2 2025 | $56.7M | +$75.6M |
| Q1 2025 | -$90M | -$63.5M |
| Q4 2024 | $274.9M | +51% |
PRGO still generates free cash flow, though less than at its 2021 peak: $168M over the past year.
PRGO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 5.3x | High |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 6.0x | High |
| Q4 2024 | 7.0x | High |
| Q3 2024 | 10.5x | High |
| Q2 2024 | 11.5x | High |
| Q1 2024 | 8.5x | High |
| Q4 2023 | 6.5x | High |
PRGO's net debt is about 5.3 years of its operating earnings (EBITDA), down from 10 years a year ago.
PRGO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.8 | Neutral |
| Stochastic | 84.4 | Overbought |
PRGO's weekly RSI is 62 (neutral) and its Stochastic is 84 (overbought).
PRGO PE vs Healthcare Sector
| Metric | PRGO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
PRGO has no meaningful PE right now: it lost money over the past year.
PRGO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.6 | 3.5% above |
| 20 week MA | $13.7 | 18% above |
| 50 week MA | $12.8 | 26% above |
| 100 week MA | $18.5 | 13% below |
| 200 week MA | $24.9 | 35% below |
PRGO has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 35% below its 200-week average.
PRGO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.9 | $44.0 | -15% |
| 2021 | $44.0 | $39.5 | -10% |
| 2022 | $39.5 | $33.0 | -16% |
| 2023 | $33.0 | $32.2 | -2.5% |
| 2024 | $32.2 | $25.6 | -20% |
| 2025 | $25.6 | $13.8 | -46% |
| 2026 YTD | $13.8 | $16.2 | +17% |
PRGO has finished every year since 2020 lower, and it's up 17% so far in 2026.